161 related articles for article (PubMed ID: 3376373)
1. [Iatrogenic tumor cell implantation in bladder cancer].
Mack D; Rammal E; Jakse G
Urologe A; 1988 Mar; 27(2):99-104. PubMed ID: 3376373
[TBL] [Abstract][Full Text] [Related]
2. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
[TBL] [Abstract][Full Text] [Related]
3. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
Skolarikos A; Chrisofos M; Ferakis N; Papatsoris A; Dellis A; Deliveliotis C
J Urol; 2005 Jun; 173(6):1908-11. PubMed ID: 15879773
[TBL] [Abstract][Full Text] [Related]
4. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
[TBL] [Abstract][Full Text] [Related]
5. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127
[TBL] [Abstract][Full Text] [Related]
6. Long-term consequences from bladder perforation and/or violation in the presence of transitional cell carcinoma: results of a small series and a review of the literature.
Mydlo JH; Weinstein R; Shah S; Solliday M; Macchia RJ
J Urol; 1999 Apr; 161(4):1128-32. PubMed ID: 10081853
[TBL] [Abstract][Full Text] [Related]
7. [A large amount of distilled water ineffective for prevention of bladder cancer cell implantation at the time of transurethral resection].
Sakai Y; Fujii Y; Hyochi N; Masuda H; Kawakami S; Kobayashi T; Kageyama Y; Kihara K
Hinyokika Kiyo; 2006 Mar; 52(3):173-5. PubMed ID: 16617868
[TBL] [Abstract][Full Text] [Related]
8. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
Jancke G; Damm O; Rosell J; Jahnson S
Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
[TBL] [Abstract][Full Text] [Related]
10. [The significance of urine cytology three consecutive days after transurethral resection as a predictor of superficial bladder cancer recurrence].
Yumura Y; Takase K; Kato Y; Hamano A; Mikata K; Ogo Y; Noguchi S; Satomi Y
Hinyokika Kiyo; 2004 Mar; 50(3):171-6. PubMed ID: 15148768
[TBL] [Abstract][Full Text] [Related]
11. The value of a second transurethral resection for T1 bladder cancer.
Schwaibold HE; Sivalingam S; May F; Hartung R
BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
[TBL] [Abstract][Full Text] [Related]
12. [The sensitivity and clinical implications of periodical bladder biopsy following transurethral resection of superficial bladder transitional cell carcinoma].
Kanematsu A; Tsuji Y; Kanba H; Noguchi T; Kamoto T; Okabe T
Hinyokika Kiyo; 2001 Jan; 47(1):1-4. PubMed ID: 11235213
[TBL] [Abstract][Full Text] [Related]
13. [Dysplastic urothelial changes in patients with bladder cancer].
Csapó Z; Kolozsy Z; Dauda G; Mohácsi L
Urologe A; 1984 Sep; 23(5):281-4. PubMed ID: 6542270
[TBL] [Abstract][Full Text] [Related]
14. Intravesical chemotherapy for superficial bladder tumors category Ta/T1: who should be treated and how?
Kurth KH
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):30-5. PubMed ID: 8727808
[TBL] [Abstract][Full Text] [Related]
15. [Studies on multiple mucosal biopsy in patients with bladder cancer. 2. Evaluation on the relationship between the results of multiple mucosal biopsy and recurrence, and the clinical course of cases with carcinoma in situ and micro-invasion of carcinoma in situ].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1633-47. PubMed ID: 3825813
[TBL] [Abstract][Full Text] [Related]
16. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
17. A second-look TUR in T1 transitional cell carcinoma: why?
Jakse G; Algaba F; Malmström PU; Oosterlinck W
Eur Urol; 2004 May; 45(5):539-46; discussion 546. PubMed ID: 15082193
[TBL] [Abstract][Full Text] [Related]
18. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
20. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years.
Holmäng S; Hedelin H; Anderström C; Johansson SL
J Urol; 1995 Jun; 153(6):1823-6; discussion 1826-7. PubMed ID: 7752327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
